Two Georgia election workers settled their defamation lawsuit against a website that falsely accused them of fraud in the ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

Is this class action suit legitimate? — D.E. Answer: It is a legitimate class action lawsuit. The lawsuit claims that Oracle, a technology company, has been compiling information on people and ...

ShareUK pharmaceutical giant, GSK said it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

A lawsuit filed against Pactiv Evergreen demanding repayment of state incentives after the company shuttered Canton’s paper ...

Michael Jordan's 23XI Racing and Front Row Motorsports — are suing NASCAR alleging a violation of antitrust laws. Here is the latest news and everything to know about the saga.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...

San Antonio attorney Mikal Watts is among a group of lawyers that negotiated a settlement of as much as $2.2 billion to resolve claims by about 80,000 people who allege a discontinued version of the ...

Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S.

KEY TAKEAWAYS GSK shares in London jumped 5% Thursday after the British pharmaceutical giant said it has resolved most of the ...

The settlement will see GSK resolve around 80,000 of the Zantac claims it faces for sums well below the $30 billion worst-case scenario figure currently priced into GSK's share price, Shore Capital ...